Laboratory for Surgical and Metabolic Research, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E678-E688. doi: 10.1152/ajpendo.00441.2019. Epub 2020 Feb 18.
Sleeve gastrectomy (SG) induces weight loss-independent improvements in glucose homeostasis by unknown mechanisms. We sought to identify the metabolic adaptations responsible for these improvements. Nonobese C57BL/6J mice on standard chow underwent SG or sham surgery. Functional testing and indirect calorimetry were used to capture metabolic phenotypes. Tissue-specific glucose uptake was assessed by 18-fluorodeoxyglucose (18-FDG) PET/computed tomography, and RNA sequencing was used for gene-expression analysis. In this model, SG induced durable improvements in glucose tolerance in the absence of changes in weight, body composition, or food intake. Indirect calorimetry revealed that SG increased the average respiratory exchange ratio toward 1.0, indicating a weight-independent, systemic shift to carbohydrate utilization. Following SG, orally administered 18-FDG preferentially localized to white adipose depots, showing tissue-specific increases in glucose utilization induced by surgery. Transcriptional analysis with RNA sequencing demonstrated that increased glucose uptake in the visceral adipose tissue was associated with upregulation in transcriptional pathways involved in energy metabolism, adipocyte maturation, and adaptive and innate immune cell chemotaxis and differentiation. SG induces a rapid, weight loss-independent shift toward glucose utilization and transcriptional remodeling of metabolic and immune pathways in visceral adipose tissue. Continued study of this early post-SG physiology may lead to a better understanding of the anti-diabetic mechanisms of bariatric surgery.
袖状胃切除术(SG)通过未知机制诱导体重减轻以外的葡萄糖稳态改善。我们试图确定负责这些改善的代谢适应。标准饮食喂养的非肥胖 C57BL/6J 小鼠接受 SG 或假手术。功能测试和间接测热法用于捕获代谢表型。通过 18-氟脱氧葡萄糖(18-FDG)PET/CT 评估组织特异性葡萄糖摄取,并用 RNA 测序进行基因表达分析。在该模型中,SG 在不改变体重、身体成分或食物摄入的情况下,可持久改善葡萄糖耐量。间接测热法显示,SG 使平均呼吸交换率向 1.0 增加,表明存在与体重无关的、全身性的碳水化合物利用转变。SG 后,口服给予的 18-FDG 优先定位于白色脂肪组织,表明手术引起的组织特异性葡萄糖利用增加。RNA 测序的转录分析表明,内脏脂肪组织中葡萄糖摄取的增加与参与能量代谢、脂肪细胞成熟以及适应性和固有免疫细胞趋化和分化的转录途径的上调有关。SG 诱导快速、与体重减轻无关的葡萄糖利用转变,并重塑内脏脂肪组织中的代谢和免疫途径的转录。对 SG 后早期生理学的进一步研究可能有助于更好地理解减重手术的抗糖尿病机制。